Summary
26 / 100 · Bulios Score
What speaks for it
- Analysts expect revenue to grow by 90% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- The price moves much more than the market (beta 4.21).
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Revenue (USD)
- Analyst estimate
For the next fiscal year analysts expect revenue to grow by 90%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $106.4M.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 9
- Hold 12
- Sell 1
Today's price within the analysts' price targets
The average target of $34.57 is 20% below today's price. 41% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Term Life Insurance 68%
- Other Products 32%
By region
The company reports no revenue by region.
Term Life Insurance brings in 68% of revenue.
Segments in detail